HomeDAWN • NASDAQ
Day One Biopharmaceuticals Inc
add
$6.93
0.72%
Pre-market:(0.72%)-0.050
$6.88
Closed: Jun 5, 7:16:10 AM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 30.76M | — |
Operating expense | 68.94M | 11.62% |
Net income | -36.00M | 42.33% |
Net profit margin | -117.02 | — |
Earnings per share | -0.35 | 51.39% |
EBITDA | -40.25M | 34.81% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 473.02M | 48.77% |
Total assets | 534.36M | 63.59% |
Total liabilities | 54.84M | 83.80% |
Total equity | 479.51M | — |
Shares outstanding | 101.36M | — |
Price to book | 1.48 | — |
Return on assets | -18.38% | — |
Return on capital | -20.79% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -36.00M | 42.33% |
Cash from operations | -59.00M | -18.64% |
Cash from investing | -32.61M | -136.53% |
Cash from financing | — | — |
Net change in cash | -91.61M | -331.30% |
Free cash flow | -46.37M | -88.75% |
Previous close
$6.98
Day range
$6.89 - $7.10
Year range
$6.08 - $16.75
Market cap
702.44M USD
Avg Volume
1.43M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
181
